key: cord-0704771-2cwv2eae
authors: Mustafa, S. Shahzad; Vadamalai, Karthik; Ramsey, Allison
title: Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations during the COVID-19 Pandemic
date: 2021-02-03
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2021.01.036
sha: be4ca7972cf0e0782895d57643171ab22b964e71
doc_id: 704771
cord_uid: 2cwv2eae

Background The novel coronavirus (COVID-19) pandemic necessitated a rapid transition from in-person evaluations to remote delivery of care, including both video and telephone visits, in allergy/immunology practices. Objective To evaluate patient satisfaction, patient and physician impression of encounter completeness, and reimbursement between in-person, video, and telephone encounters. This study also assessed factors influencing patient satisfaction, perception of completeness, and choice of future evaluation type. Methods This was a prospective study of all encounters at a healthcare-system owned practice. Encounter type, encounter modality, patient demographics, primary diagnoses, reimbursement data, and physician assessment of encounter completeness were tracked. Patient satisfaction was assessed via standardized questions. Results There were 447 encounters, with 303 (67.8%) in-person, 98 (21.9%) video, and 46 (10.3%) telephone. Patient satisfaction data was obtained from 251 patients. There was similar patient satisfaction among all encounter modalities. Both patients and physicians were more likely to deem an in-person encounter as complete. Physicians were more likely to report an in-person encounter to be complete for food allergy (p<0.001) and chronic rhinitis (p=0.001) as compared to video or telephone, whereas patients reported in-person encounters for food allergy to be complete as compared to other modalities (p=0.002). Patients reported that future encounter types should depend on the clinical situation. Conclusions There was similar patient satisfaction with in-person, video, and telephone encounters in an allergy/immunology practice during the COVID-19 pandemic. Chronic rhinitis and food allergy are more likely to call for an in-person evaluation. New patient visits are likely to be the most high-yield to focus on for in-person evaluations.

The novel coronavirus (COVID-19) pandemic necessitated a rapid transition from in-person evaluations 32 to remote delivery of care, including both video and telephone visits, in allergy/immunology practices. 33

Objective 34

To evaluate patient satisfaction, patient and physician impression of encounter completeness, and 35 reimbursement between in-person, video, and telephone encounters. This study also assessed factors 36 influencing patient satisfaction, perception of completeness, and choice of future evaluation type. 37

This was a prospective study of all encounters at a healthcare-system owned practice. Encounter type, 39 encounter modality, patient demographics, primary diagnoses, reimbursement data, and physician 40 assessment of encounter completeness were tracked. Patient satisfaction was assessed via standardized 41 questions. 42

There were 447 encounters, with 303 (67.8%) in-person, 98 (21.9%) video, and 46 (10.3%) telephone. 44

Patient satisfaction data was obtained from 251 patients. There was similar patient satisfaction among 45 all encounter modalities. Both patients and physicians were more likely to deem an in-person encounter 46 as complete. Physicians were more likely to report an in-person encounter to be complete for food 47 allergy (p<0.001) and chronic rhinitis (p=0.001) as compared to video or telephone, whereas patients 48 reported in-person encounters for food allergy to be complete as compared to other modalities 49 (p=0.002). Patients reported that future encounter types should depend on the clinical situation. Patient satisfaction with remote visits during the COVID-19 pandemic has previously been reported. 74

This study demonstrates similar patient satisfaction among in-person, video, and telephone encounters, 76 but shows that patients and physicians were most likely to report encounter completeness with in-77 person visits, especially with food allergy and chronic rhinitis. There was no difference between video 78 and telephone encounter perception of completeness among patients and physicians. 79

This information can be immediately applied to scheduling patients in allergy/immunology practices to 81 optimize space, time, and safety during the COVID-19 pandemic. 

The term telemedicine was first used in the 1970s. Taken literally, it means "health from a distance" 1 . 112 Historically, this "distance" was physical distance from healthcare access, and telemedicine helped to 113 overcome this barrier. However, at the onset of the novel coronavirus disease 2019 (COVID-19) global 114 pandemic, the "distance" became social in nature, due to widespread recommendations aimed at 115 mitigating virus transmission 2 . Many healthcare providers, including allergy/immunology specialists, 116 were forced to quickly change their mode of care delivery from in-person evaluations to telemedicine 117 evaluations, including both video and telephone encounters 3 . The widespread adoption of telemedicine 118 was in contrast to prior to the COVID-19 pandemic, where allergy/immunology uptake of telemedicine 119 had been minimal 4 . 120

Multiple studies have previously demonstrated patient satisfaction with telemedicine during the COVID-121 19 pandemic 5-7 . Though the pandemic persists, case numbers, increased testing, use of personal 122 protective equipment (PPE), and the need to maintain economic viability has allowed for opening of 123 medical facilities for non-emergent and routine in-person encounters. Previous reports 5-7 regarding 124 telemedicine focused only on video visits, and did not include patient satisfaction data regarding in-125 person or telephone versus video encounters during the same time period. 126

The New York on Pause 8 measures successfully decreased the prevalence of COVID-19 by early summer, 127 allowing our health care system to resume in-person evaluations in May 2020, though our 128 allergy/immunology practice continued video and telephone encounters in addition to in-person 129 evaluations. We therefore sought to compare patient satisfaction among different encounter 130 modalities, provider and patient assessment of visit completeness, and reimbursement information 131 across modalities. We also assessed whether patient demographics and primary diagnoses influenced 132 patient satisfaction, perception of completeness, and choice of future evaluation type. 133

This was a single-center, prospective study conducted by two allergy/immunology physicians at the 137 Rochester Regional Health Allergy/Immunology practice, a healthcare system-owned practice, in 138

Rochester, NY, from June 26, 2020 through July 31, 2020. 1. What is your current level of concern of being exposed to COVID-19 during a doctor visit? 153

Not concerned, minimally concerned, very concerned 154 J o u r n a l P r e -p r o o f Strongly disagree, disagree, neutral, agree, strongly agree 156 3. My in-person/video/telephone encounter resulted in a complete evaluation 157

Yes, no 158 4. In the future, I would prefer the following visit type 159

In-person, video, telephone, any would be acceptable, depends on clinical situation 160 5. Patient copays should be the same regardless of appointment type 161 Strongly disagree, disagree, neutral, agree, strongly agree 162 6. What is the most important reason you would prefer an in-person encounter? 163 7. What is the most important reason you would prefer a video or telephone encounter? 164

The primary outcome measures were patient satisfaction with each encounter modality. In addition, we 166 assessed if there was an association between physician and patient impression of evaluation 167 completeness depending on encounter type, primary diagnosis, age, and gender. We also assessed if 168 there was an association between patient level of concern for COVID-19 and encounter type. were via video, and 46 (10.3%) were via telephone (Table 1) . For the in-person group, the median age 183 was 20 years (interquartile range (IQR): 6-53), 167 (55%) were female, 184 (60.7%) were NP visits, and 184 119 (39.3%) were FU visits. The most common primary diagnoses for in-person encounters were food 185 allergy (33.3%), chronic rhinitis/sinusitis (22.4%), and asthma (10.2%). For the video group, the median 186 age was 29 years (IQR: 11-53), 57 (58.1%) were female, 6 (6.1%) were NP, and 92 (93.9%) were FU visits. 187

The most common primary diagnoses for video encounters were asthma (29.5%), chronic 188 rhinitis/sinusitis (26.5%), and food allergy (16.3%). The most common video platform used was 189 FaceTime, in 63% of patients, followed by Doximity in 23% of patients ( Figure 1 ). For the telephone 190 group, the median age was 48 (IQR: 29-61), 33 (71.7%) were female, and all 46 evaluations were FUs. 191

The most common primary diagnoses in the telephone encounters were chronic rhinitis/sinusitis 192 (32.6%), asthma (28.3%), and food allergy (10.9%). See Table 1 completeness (p=0.682). Additionally, physicians were more likely to report in-person evaluations to be 208 complete for food allergy (p<0.001) and chronic rhinitis (p=0.001) as compared to other encounter 209 modalities. There was no significant difference between encounter modality and physician reported 210 completeness for other diagnoses, including asthma and urticaria (Table 3a) . Patients evaluated for food 211 allergy were more likely to report an in-person evaluation to be complete as compared to a video or 212 telephone visit (p=0.002) ( The most commonly cited reason that patients preferred an in-person encounter was to have a physical 218 exam (25.9%) ( Table 4 ). Patients almost equally cited that "in-person care is better for serious 219 allergy and/or breathing tests." The most common reasons cited for utilizing a video or telephone 221 encounter were "routine follow up or simple visit" (32.8%), "more convenient" (23.8%) and that they 222 "feel safer during COVID-19 pandemic" (13.5%) ( Our analysis is the first to compare allergy/immunology in-person, video, and telephone encounters 234 during the COVID-19 pandemic. Importantly, we demonstrate comparable patient satisfaction across all 235 encounter types. We show that both physicians and patients reported the highest visit completeness for 236 in-person encounters, but there was no difference between video and telephone encounters. This is an important finding that we did not analyze for our study. Importantly, Kahwash et al recently 257 demonstrated that the majority of allergy/immunology trainees have also used remote evaluations and 258 are comfortable doing so, which is helpful when planning for implementation of telemedicine following 259 the COVID-19 pandemic 10 . 260

Our data add to the existing and growing body of literature regarding the expanding role of telemedicine 261 visits in the allergy/immunology field 11,12 . As we continue to face the COVID-19 pandemic, emerging 262 data are reassuring that patients are satisfied with their evaluations regardless of encounter type, and 263 provides guidance for targeting specific diagnoses for certain encounter modalities 9 . Food allergy and 264 diagnostic testing such as skin testing, whereas urticaria may be adequately addressed via video or 266 telephone encounters. Our data also show that patients believe encounter modality should depend on 267 the clinical situation, and this presents an opportunity for shared decision making when deciding how to 268 schedule future appointments. Surprisingly, there was no difference in comfort using telemedicine with 269 respect to age. We believe this information can be immediately applied to scheduling patients in 270 allergy/immunology practices to optimize space, time, and safety during the COVID-19 pandemic. 271

During the course of our study, our office focused on scheduling NPs for in-person encounters. We 272 believe this is the most practical approach, as we demonstrate that an in-person NP encounter was most 273 likely to result in an impression of a complete visit and maximal reimbursement as compared to other 274 encounter types. We previously demonstrated that video and telephone encounters alone are not likely 275 to be financially sustainable for an allergy immunology practice 3 , and this current hybrid scheduling 276 approach is more sustainable. In our analysis, patients also expressed wishes to have in-person 277 evaluations for physical exams, building rapport with their physician, and for necessary diagnostic 278 testing. A NP in-person evaluation accomplishes all of these goals, and then may lay the groundwork to 279 have productive subsequent video or telephone visits. Patients were agreeable to video and telephone 280 encounters for routine or simple follow up, and cited convenience as a strength of these encounters. 281

Although telephone encounters did not reimburse as well as video encounters, our analysis 282 demonstrates that these modalities were deemed equally complete by patients and physicians. We 283 therefore offer that telephone encounters may be easily added on to a provider schedule as a way to 284 maintain patient access for short, routine follow ups without concern for technological barriers with 285 video encounters or space considerations for in-person evaluations. 286 J o u r n a l P r e -p r o o f to the survey, and these patients may have had an established physician/patient relationship with the 288 authors. Despite being contacted by an independent research nurse, there is likely to be an element of 289 response bias for both of these reasons. Although including pediatric patients is a strength of our 290 analysis, parents answered on behalf of their children for satisfaction survey. We also did not evaluate 291 patient satisfaction with respect to reported race or language spoken, and this may have been 292 enlightening in regards to health care disparities. Even though a larger sample size is always desirable, 293 we wished to put forth this information in a timely manner during the COVID-19 pandemic. Lastly, our 294 results and suggestions for practical implementation of various encounter modalities will depend on the 295 local response to the COVID-19 pandemic, which varies greatly from state to state. Additionally, the 296 practice setting (private versus academic) will likely also significantly contribute to these decisions based 297 on varying reimbursement models. 298

In summary, we demonstrate patient satisfaction with in-person, video, and telephone encounters in an 299 allergy/immunology practice during the COVID-19 pandemic. Certain diagnoses, such as urticaria lend 300 themselves particularly well to a remote evaluation, whereas chronic rhinitis and food allergy are more 301 likely to necessitate an in-person encounter. New patient visits are likely to be the most high-yield to 302 focus on for in-person evaluations. We believe that our data will help allergy/immunology practices 303 optimize patient scheduling during the COVID-19 pandemic and beyond. J o u r n a l P r e -p r o o f Only if doctor's office closed 10 (4.5%)

Quicker access to an appointment 6 (2.7%) J o u r n a l P r e -p r o o f Figure 1 In J o u r n a l P r e -p r o o f 

One hundred years of telemedicine: does this new technology have a place in 310 paediatrics?

COVID-19: pandemic 312 contingency planning for the allergy and immunology clinic

Appointment characteristics in an allergy/immunology 315 practice in the immediate aftermath of COVID-19 restrictions

The use of telemedicine by physicians: still the exception rather than the rule

Telemedicine in the Era of COVID-19

Patient satisfaction with telemedicine encounters in an 321 allergy and immunology practice during the coronavirus disease 2019 pandemic

Patient satisfaction and utilization of telemedicine services in allergy: an 324 institutional survey

New York State Information on Novel Coronavirus